Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia

Authors: Raal F.J.; Pilcher G.J.; Illingworth D.R.; Pappu A.S.; Stein E.A.; Laskarzewski P.; Mitchel Y.B.; Melino M.R.

Source: Atherosclerosis, Volume 135, Number 2, December 1997 , pp. 249-256(8)

Publisher: Elsevier

Keywords: HMG CoA reductase inhibitors; Simvastatin; Low density lipoprotein-cholesterol; Homozygous familial hypercholesterolaemia

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0021-9150(97)00168-8

Affiliations: 1: Carbohydrate and Lipid Metabolism Research Group, Department of Medicine, University of the Witwatersrand, 7 York Road, Parktown, 2193 Johannesburg, South Africa

Publication date: 1997-12-01

• In this: publication
• By this: publisher
• In this Subject: Cardiovascular Medicine
• By this author: Raal F.J. ;  Pilcher G.J. ;  Illingworth D.R. ;  Pappu A.S. ;  Stein E.A. ;  Laskarzewski P. ;  Mitchel Y.B. ;  Melino M.R.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers